B-lymphocyte hemostasis and anti-B-cell therapy areas for rheumatoid arthritis by Ekaterina Valeryevna Suponitskaya, E N Aleksandrova, A P Aleksankin, E L Nasonov

Get full text

IMPACT OF THERAPY WITH BIOLOGICAL AGENTS ON B-LYMPHOCYTE SUBPOPULATIONS IN RHEUMATIC DISEASES: NEW EVIDENCE by E. V. Suponitskaya, E. N. Aleksandrova, A. P. Aleksankin, E. L. Nasonov

Get full text

The role of NETosis in the pathogenesis of immunoinflammatory rheumatic diseases by E. L. Nasonov, A. S. Avdeeva, T. M. Reshetnyak, A. P. Aleksankin, Yu. P. Rubtsov

Get full text

B-lymphocyte subpopulations in patients with rheumatoid arthritis and the effect of an interleukin-6 receptor inhibitor on them. by E. V. Gerasimova, T. V. Popkova, A. P. Aleksankin, A. V. Martynova, E. L. Nasonov

Get full text

FEATURES OF THE PHENOTYPE OF REGULATORY T CELLS IN EARLY AND ADVANCED RHEUMATOID ARTHRITIS by A. S. Avdeeva, Yu. P. Rubtsov, T. V. Popkova, D. T. Dyikanov, A. P. Aleksankin, E. L. Nasonov

Get full text

Effect of biological agents on B-lymphocyte subpopulations in patients with systemic lupus erythematosus by A. A. Mesnyankina, S. K. Solovyev, E. A. Aseeva, A. P. Aleksankin, E. N. Aleksandrova, E. L. Nasonov

Get full text

DUAL THERAPY WITH BIOLOGICALS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS by A. A. Mesnyankina, S. K. Solovyev, E. N. Aleksandrova, A. P. Aleksankin, E. A. Aseeva, E. L. Nasonov

Get full text

Dynamics of T- and B-lymphocytes in patients with rheumatoid arthritis, receiving biological disease-modifying antirheumatic drugs by A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. M. Lila

Get full text

T- and B-lymphocytes subpopulations in the early and advanced rheumatoid arthritis by A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. S. Semashko, A. M. Lila

Get full text

THE TIME COURSE OF CHANGES IN B LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING THERAPY WITH BIOLOGICAL AGENTS by A. A. Mesnyankina, S. K. Solovyev, E. N. Aleksandrova, A. P. Aleksankin, E. V. Suponitskaya, A. V. Elonakov, E. A. Aseeva, E. L. Nasonov

Get full text

GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM by E. V. Ostryakova, N. L. Patrusheva, A. P. Aleksankin, L. I. Patrushev, N. V. Seredavkina, E. N. Aleksandrova, A. V. Volkov, T. M. Reshetnyak

Get full text

RITUXIMAB THERAPY MONITORING IN PATIENTS WITH RHEUMATOID ARTHRITIS HROUGH PERIPHERAL BLOOD GENE EXPRESSION ANALYSIS by E. V. Chetina, A. V. Pivanova, K. Kh. Kuzikyants, A. Yu. Devyataikina, G. V. Lukina, E. Yu. Samarkina, A. P. Aleksankin, E. N. Aleksandrova

Get full text

DNA double-strand breaks in immunoinflammatory rheumatic diseases by A. S. Avdeeva, A. P. Aleksankin, Zh. G. Verizhnikova, V. V. Rybakova, M. E. Diatroptov, Yu. N. Gorbunova, A. A. Mesnyankina, D. A. Paranich, A. M. Lila, E. L. Nasonov

Get full text

Effect of rituximab on the manifestations of activity and pulmonary function in patients with systemic sclerosis: one-year follow-up evaluation by L. P. Ananyeva, O. A. Koneva, O. V. Desinova, L. A. Garzanova, S. I. Glukhova, M. N. Starovoitova, O. B. Ovsyannikova, A. V. Volkov, A. P. Aleksankin, E. L. Nasonov

Get full text

Anti-topoisomerase 1 antibody level changes after B сell depletion therapy in systemic sclerosis by L. P. Ananyeva, L. A. Garzanova, O. A. Koneva, M. N. Starovoytova, O. V. Desinova, O. B. Ovsyannikova, R. U. Shayakhmetova, M. V. Cherkasova, A. P. Aleksankin, E. L. Nasonov

Get full text

RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA by Lidia Petrovna Ananieva, O V Desinova, O A Koneva, M N Starovoitova, N N Yutkina, A V Volkov, O B Ovsyannikova, A P Aleksankin, E N Aleksandrova, A A Novikov, E L Nasonov

Get full text